This is the second in a three-part blog series on National Pharmacovigilance systems and the role of technology in bridging the gaps in pharmacovigilance of regulatory authorities around the world.
It is with great excitement that we announce that Nordic Capital has entered into a definitive agreement to acquire ArisGlobal. Over these 32 years, ArisGlobal has built a sustainable and growing business that thrives on its partnerships with many life sciences companies and regulatory agencies. These customer relationships, some lasting decades, have allowed ArisGlobal to become a leading healthcare technology company with over 1200 employees across an expansive global footprint.
One of the key roles of pharmacovigilance departments is to understand the benefit-risk profile of a drug. But departments are often bogged down by manual tasks that can absorb time, which might be better spent on value-centric activities. Perhaps the most tedious pharmacovigilance activity is medical literature monitoring (MLM), and as we discussed in our last blog, manual, repetitive tasks are a primary cause of employee dissatisfaction.
On June 5th, 2019, ArisGlobal held a webinar focused on the “Key Use Cases of Automation in Pharmacovigilance.” During that event, 84% of attendees indicated a significant increase in their case volumes over the last five years. Only 15% considered their case volume increases to be ‘slight.’
As the outsourcing trend continues to grow, many biopharmaceutical and ...
Your team’s workload grows by the day. The volume of Safety cases you’re ...
South Korean Contract Research Organization, LSK, spoke in a webinar ...
The ArisGlobal marketing department spent time with Clint Wolfe, Chief Human Resources Officer. They discussed changes at ArisGlobal, working from home, how different areas of the globe are handling COVID-19 differently, and more.
There has been significant changes in the way the EMA expects MAHs to handle ICSRs from the new EudraVigilance system, creating additional work for already busy pharmacovigilance departments
Safety departments at Marketing Authorization Holders & Regulatory Authorities are ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved
